Skip to main content
Top
Published in: Inflammation 3/2009

01-06-2009

CCL18 Production is Decreased in Alveolar Macrophages from Cigarette Smokers

Authors: Florian Kollert, Corina Probst, Joachim Müller-Quernheim, Gernot Zissel, Antje Prasse

Published in: Inflammation | Issue 3/2009

Login to get access

Abstract

It is generally known that cigarette smoke alters the activation of alveolar macrophages (AM). CC Chemokine Ligand 18 (CCL18) is a marker of alternatively activated macrophages and is highly expressed in the lung. This study examines the influence of chronic cigarette smoking on the expression of CCL18 by AM. Bronchoalveolar lavage (BAL) and serum were obtained from ten smokers and 14 non-smokers. CCL18 protein concentrations were measured in serum and BAL fluid (BALF) as well as in supernatants from BAL-cells by enzyme-linked immunosorbent assay. In this study we show that the CCL18 production of BAL-cells from smokers was significantly decreased compared to BAL-cells from non-smokers. The BALF CCL18 protein concentration per macrophage cell count was significantly reduced in smokers. Furthermore, we show a decrease in CCL18 production from BAL-cells after stimulation with LPS. This decrease in CCL18 production was only shown in BAL-cells from non-smokers, which is probably due to chronic LPS exposure of smokers, resulting in LPS hypo-responsiveness. No statistically significant difference of CCL18 concentrations was found in BALF or serum of smokers versus non-smokers. CCL18 production by BAL-cells is down-regulated by chronic cigarette smoking and LPS contamination in cigarette smoke might be one factor involved. Thus this article gives further evidence that chronic cigarette smoking alters the phenotype of AM and that the M2 marker CCL18 is down-regulated in smokers macrophages.
Literature
1.
go back to reference Baumgartner, K. B., J. M. Samet, C. A. Stidley, T. V. Colby, and J. A. Waldron. 1997. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 155(1):242–248.PubMed Baumgartner, K. B., J. M. Samet, C. A. Stidley, T. V. Colby, and J. A. Waldron. 1997. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 155(1):242–248.PubMed
7.
go back to reference Prasse, A., D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel. 2006. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care. Med. 173(7):781–792. doi:10.1164/rccm.200509-1518OC.PubMedCrossRef Prasse, A., D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel. 2006. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care. Med. 173(7):781–792. doi:10.​1164/​rccm.​200509-1518OC.PubMedCrossRef
8.
go back to reference Prasse, A., D. V. Pechkovsky, G. B. Toews, M. Schafer, S. Eggeling, C. Ludwig, M. Germann, F. Kollert, G. Zissel, and J. Muller-Quernheim. 2007. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis. Rheum. 56(5):1685–1693. doi:10.1002/art.22559.PubMedCrossRef Prasse, A., D. V. Pechkovsky, G. B. Toews, M. Schafer, S. Eggeling, C. Ludwig, M. Germann, F. Kollert, G. Zissel, and J. Muller-Quernheim. 2007. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis. Rheum. 56(5):1685–1693. doi:10.​1002/​art.​22559.PubMedCrossRef
9.
go back to reference Goerdt, S., O. Politz, K. Schledzewski, R. Birk, A. Gratchev, P. Guillot, N. Hakiy, C. D. Klemke, E. Dippel, V. Kodelja, and C. E. Orfanos. 1999. Alternative versus classical activation of macrophages. Pathobiology. 67(5–6):222–226. doi:10.1159/000028096.PubMedCrossRef Goerdt, S., O. Politz, K. Schledzewski, R. Birk, A. Gratchev, P. Guillot, N. Hakiy, C. D. Klemke, E. Dippel, V. Kodelja, and C. E. Orfanos. 1999. Alternative versus classical activation of macrophages. Pathobiology. 67(5–6):222–226. doi:10.​1159/​000028096.PubMedCrossRef
11.
go back to reference Guan, P., A. H. Burghes, A. Cunningham, P. Lira, W. H. Brissette, K. Neote, and S. R. McColl. 1999. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18. Genomics. 56(3):296–302. doi:10.1006/geno.1998.5635.PubMedCrossRef Guan, P., A. H. Burghes, A. Cunningham, P. Lira, W. H. Brissette, K. Neote, and S. R. McColl. 1999. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18. Genomics. 56(3):296–302. doi:10.​1006/​geno.​1998.​5635.PubMedCrossRef
12.
go back to reference Hieshima, K., T. Imai, M. Baba, K. Shoudai, K. Ishizuka, T. Nakagawa, J. Tsuruta, M. Takeya, Y. Sakaki, K. Takatsuki, R. Miura, G. Opdenakker, D. J. Van, O. Yoshie, and H. Nomiyama. 1997. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol. 159(3):1140–1149.PubMed Hieshima, K., T. Imai, M. Baba, K. Shoudai, K. Ishizuka, T. Nakagawa, J. Tsuruta, M. Takeya, Y. Sakaki, K. Takatsuki, R. Miura, G. Opdenakker, D. J. Van, O. Yoshie, and H. Nomiyama. 1997. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol. 159(3):1140–1149.PubMed
13.
go back to reference Kodelja, V., C. Muller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt. 1998. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 160(3):1411–1418.PubMed Kodelja, V., C. Muller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt. 1998. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 160(3):1411–1418.PubMed
15.
go back to reference Prasse, A., M. Germann, D. V. Pechkovsky, A. Markert, T. Verres, M. Stahl, I. Melchers, W. Luttmann, J. Muller-Quernheim, and G. Zissel. 2007. IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J. Allergy. Clin. Immunol. 119(2):464–471. doi:10.1016/j.jaci.2006.09.030.PubMedCrossRef Prasse, A., M. Germann, D. V. Pechkovsky, A. Markert, T. Verres, M. Stahl, I. Melchers, W. Luttmann, J. Muller-Quernheim, and G. Zissel. 2007. IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J. Allergy. Clin. Immunol. 119(2):464–471. doi:10.​1016/​j.​jaci.​2006.​09.​030.PubMedCrossRef
16.
go back to reference Prasse, A., C. Probst, E. Bargagli, G. Zissel, G. B. Toews, K. R. Flaherty, M. Olschewski, P. Rottoli, J. Muller-Quernheim. Serum CC–chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009 February 6. Prasse, A., C. Probst, E. Bargagli, G. Zissel, G. B. Toews, K. R. Flaherty, M. Olschewski, P. Rottoli, J. Muller-Quernheim. Serum CC–chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009 February 6.
17.
go back to reference Cottin, V., H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblonde, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, and Groupe d’Etude et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). 2005. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 26:586–593.PubMedCrossRef Cottin, V., H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblonde, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, and Groupe d’Etude et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). 2005. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 26:586–593.PubMedCrossRef
18.
go back to reference Woodruff, P. G., L. L. Koth, Y. H. Yang, M. W. Rodriguez, S. Favoreto, G. M. Dolganov, A. C. Paquet, and D. J. Erle. 2005. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am. J. Respir. Crit. Care. Med. 172(11):1383–1392. doi:10.1164/rccm.200505-686OC.PubMedCrossRef Woodruff, P. G., L. L. Koth, Y. H. Yang, M. W. Rodriguez, S. Favoreto, G. M. Dolganov, A. C. Paquet, and D. J. Erle. 2005. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am. J. Respir. Crit. Care. Med. 172(11):1383–1392. doi:10.​1164/​rccm.​200505-686OC.PubMedCrossRef
19.
go back to reference Heguy, A., T. P. O'Connor, K. Luettich, S. Worgall, A. Cieciuch, B. G. Harvey, N. R. Hackett, and R. G. Crystal. 2006. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J. Mol. Med. 84(4):318–328. doi:10.1007/s00109-005-0008-2.PubMedCrossRef Heguy, A., T. P. O'Connor, K. Luettich, S. Worgall, A. Cieciuch, B. G. Harvey, N. R. Hackett, and R. G. Crystal. 2006. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J. Mol. Med. 84(4):318–328. doi:10.​1007/​s00109-005-0008-2.PubMedCrossRef
22.
go back to reference Atamas, S. P., I. G. Luzina, J. Choi, N. Tsymbalyuk, N. H. Carbonetti, I. S. Singh, M. Trojanowska, and S. A. Jimenez. 2003. White B. Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 29(6):743–749. doi:10.1165/rcmb.2003-0078OC.PubMedCrossRef Atamas, S. P., I. G. Luzina, J. Choi, N. Tsymbalyuk, N. H. Carbonetti, I. S. Singh, M. Trojanowska, and S. A. Jimenez. 2003. White B. Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 29(6):743–749. doi:10.​1165/​rcmb.​2003-0078OC.PubMedCrossRef
24.
25.
go back to reference Pivarcsi, A., M. Gombert, M. C. eu-Nosjean, A. Lauerma, R. Kubitza, S. Meller, J. Rieker, A. Muller, C. L. Da, A. Haahtela, E. Sonkoly, W. H. Fridman, H. Alenius, L. Kemeny, T. Ruzicka, A. Zlotnik, and B. Homey. 2004. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J. Immunol. 173(9):5810–5817.PubMed Pivarcsi, A., M. Gombert, M. C. eu-Nosjean, A. Lauerma, R. Kubitza, S. Meller, J. Rieker, A. Muller, C. L. Da, A. Haahtela, E. Sonkoly, W. H. Fridman, H. Alenius, L. Kemeny, T. Ruzicka, A. Zlotnik, and B. Homey. 2004. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J. Immunol. 173(9):5810–5817.PubMed
26.
go back to reference Bingisser, R., R. Speich, A. Zollinger, E. Russi, and K. Frei. 2000. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis. Respiration. 67(3):280–286. doi:10.1159/000029511.PubMedCrossRef Bingisser, R., R. Speich, A. Zollinger, E. Russi, and K. Frei. 2000. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis. Respiration. 67(3):280–286. doi:10.​1159/​000029511.PubMedCrossRef
27.
go back to reference Salez, L., V. Balloy, R. N. van, M. Lebastard, L. Touqui, F. X. McCormack, and M. Chignard. 2001. Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. J. Immunol. 166(10):6376–6382.PubMed Salez, L., V. Balloy, R. N. van, M. Lebastard, L. Touqui, F. X. McCormack, and M. Chignard. 2001. Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. J. Immunol. 166(10):6376–6382.PubMed
28.
go back to reference Vulcano, M., S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, A. Mantovani, D. J. Van, and S. Sozzani. 2003. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 170(7):3843–3849.PubMed Vulcano, M., S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, A. Mantovani, D. J. Van, and S. Sozzani. 2003. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 170(7):3843–3849.PubMed
Metadata
Title
CCL18 Production is Decreased in Alveolar Macrophages from Cigarette Smokers
Authors
Florian Kollert
Corina Probst
Joachim Müller-Quernheim
Gernot Zissel
Antje Prasse
Publication date
01-06-2009
Publisher
Springer US
Published in
Inflammation / Issue 3/2009
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-009-9115-5

Other articles of this Issue 3/2009

Inflammation 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.